Research of gemcitabine sensitivity in pancreatic cancer.
Not Applicable
- Conditions
- Advanced pancreatic cancer
- Registration Number
- JPRN-UMIN000006840
- Lead Sponsor
- Gifu University Dept. of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Advanced pancreatic cancer could not be diagnosed by EUS-FNA.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate and prognosis of chmotherapy with GEM.
- Secondary Outcome Measures
Name Time Method